We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$644M
AUM Growth
+$320M
Cap. Flow
+$288M
Cap. Flow %
44.77%
Top 10 Hldgs %
23.99%
Holding
104
New
10
Increased
74
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
TEX icon
Terex
TEX
+$12.8M
2
ROC
ROCKWOOD HLDGS INC
ROC
+$12.6M
3
ININ
Interactive Intelligence Group, inc.
ININ
+$11.5M
4
MDVN
MEDIVATION, INC.
MDVN
+$9.57M
5
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$8.71M

Top Sells

Rank Stock Value
1
DWSN
DAWSON GEOPHYSICAL CO
DWSN
+$2.21M
2
TRAW icon
Traws Pharma
TRAW
+$264K
3
VVUS
Vivus Inc
VVUS
+$253K

Sector Composition

Rank Sector Weight
1 Healthcare 23.69%
2 Consumer Discretionary 13.71%
3 Technology 11.28%
4 Industrials 11%
5 Materials 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
51
Tesla
TSLA
$1.22T
$5.48M 0.85%
394,500
+180,000
+84% +$2.41M
AZPN
52
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$5.44M 0.85%
128,500
– –
CLDX icon
53
Celldex Therapeutics
CLDX
$3.02B
$5.1M 0.79%
19,247
+2,114
+12% +$809K
PWR icon
54
Quanta Services
PWR
$98.7B
$4.95M 0.77%
134,000
+54,900
+69% +$1.83M
ACAD icon
55
Acadia Pharmaceuticals
ACAD
$4.55B
$4.71M 0.73%
193,500
+18,100
+10% +$458K
PBYI icon
56
Puma Biotechnology
PBYI
$402M
$4.68M 0.73%
44,900
+2,800
+7% +$329K
SJM icon
57
J.M. Smucker
SJM
$13.1B
$4.51M 0.7%
46,400
+10,300
+29% +$1M
SZYM
58
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$4.23M 0.66%
364,000
+122,800
+51% +$1.44M
NOV icon
59
NOV
NOV
$6.93B
$3.7M 0.57%
52,678
– –
TTPH
60
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$3.28M 0.51%
15,045
+10,215
+211% +$2.85M
ATRC icon
61
AtriCure
ATRC
$2.04B
$2.71M 0.42%
143,800
+74,500
+108% +$1.53M
ECYT
62
DELISTED
Endocyte, Inc. Common Stock
ECYT
$2.33M 0.36%
98,000
+52,300
+114% +$758K
PRTA icon
63
Prothena Corp
PRTA
$440M
$2.23M 0.35%
+58,300
New +$1.88M
SLXP
64
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$2.12M 0.33%
20,500
+11,500
+128% +$1.18M
KPTI icon
65
Karyopharm Therapeutics
KPTI
$159M
$2.09M 0.33%
4,520
+2,547
+129% +$1.29M
CERN
66
DELISTED
Cerner Corp
CERN
$2.07M 0.32%
+36,800
New +$2.12M
CBST
67
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$2M 0.31%
27,400
+15,500
+130% +$1.16M
CLVS
68
DELISTED
Clovis Oncology, Inc.
CLVS
$1.96M 0.3%
+28,300
New +$2.08M
SUPN icon
69
Supernus Pharmaceuticals
SUPN
$2.65B
$1.93M 0.3%
+215,500
New +$1.98M
BMRN icon
70
BioMarin Pharmaceuticals
BMRN
$11.7B
$1.92M 0.3%
28,100
+17,700
+170% +$1.3M
SAAS
71
DELISTED
inContact, Inc.
SAAS
$1.86M 0.29%
193,300
– –
HPTX
72
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.85M 0.29%
71,700
+40,500
+130% +$1.1M
NTUS
73
DELISTED
Natus Medical Inc
NTUS
$1.83M 0.28%
71,100
+40,300
+131% +$1.02M
OMED
74
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.78M 0.28%
52,800
+30,300
+135% +$1.02M
BRKR icon
75
Bruker
BRKR
$9.79B
$1.68M 0.26%
73,900
+43,300
+142% +$944K
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Eventide Asset Management held 104 positions worth $644M, up 98% from $325M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $288M of net new capital in Q1 2014, opening 10 new positions and adding to 74 existing holdings. Its largest new stake was Terex: 303,500 shares worth $13.4M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the most notable exit was DAWSON GEOPHYSICAL CO, an estimated $2.21M sold.

  • Eventide Asset Management's largest Q1 2014 buy was Terex: 303,500 shares worth $13.4M.
  • Eventide Asset Management added most to Interactive Intelligence Group, inc. in Q1 2014, an estimated $11.5M increase.
  • Eventide Asset Management fully exited DAWSON GEOPHYSICAL CO in Q1 2014, selling an estimated $2.21M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $644M portfolio in Q1 2014.
  • Eventide Asset Management opened 10 new positions and closed 2 in Q1 2014.
  • Eventide Asset Management's portfolio value rose 98% quarter-over-quarter to $644M.

Based on Eventide Asset Management's 13F filing for Q1 2014, filed 13 May 2014.